A New Panel-Based Next-Generation Sequencing Method for ADME Genes Reveals Novel Associations of Common and Rare Variants With Expression in a Human Liver Cohort.

ADME eQTL analysis next generation sequencing pharmacogenomics rare variants

Journal

Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621

Informations de publication

Date de publication:
2019
Historique:
received: 26 10 2018
accepted: 09 01 2019
entrez: 16 2 2019
pubmed: 16 2 2019
medline: 16 2 2019
Statut: epublish

Résumé

We developed a panel-based NGS pipeline for comprehensive analysis of 340 genes involved in absorption, distribution, metabolism and excretion (ADME) of drugs, other xenobiotics, and endogenous substances. The 340 genes comprised phase I and II enzymes, drug transporters and regulator/modifier genes within their entire coding regions, adjacent intron regions and 5' and 3'UTR regions, resulting in a total panel size of 1,382 kbp. We applied the ADME NGS panel to sequence genomic DNA from 150 Caucasian liver donors with available comprehensive gene expression data. This revealed an average read-depth of 343 (range 27-811), while 99% of the 340 genes were covered on average at least 100-fold. Direct comparison of variant annotation with 363 available genotypes determined independently by other methods revealed an overall accuracy of >99%. Of 15,727 SNV and small INDEL variants, 12,022 had a minor allele frequency (MAF) below 2%, including 8,937 singletons. In total we found 7,273 novel variants. Functional predictions were computed for coding variants (

Identifiants

pubmed: 30766545
doi: 10.3389/fgene.2019.00007
pmc: PMC6365429
doi:

Types de publication

Journal Article

Langues

eng

Pagination

7

Références

Pharmacogenetics. 2000 Oct;10(7):577-81
pubmed: 11037799
Clin Pharmacol Ther. 2004 Aug;76(2):128-38
pubmed: 15289790
Nat Rev Genet. 2004 Sep;5(9):669-76
pubmed: 15372089
Arch Neurol. 2005 Jan;62(1):74-8
pubmed: 15642852
Pharmacogenomics. 2009 Apr;10(4):579-99
pubmed: 19374516
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Hepatology. 2010 Feb;51(2):491-500
pubmed: 20101753
P T. 2009 Aug;34(8):422-7
pubmed: 20140106
Pharmacogenomics J. 2013 Feb;13(1):12-20
pubmed: 22006096
Hepatology. 2012 Jun;55(6):1912-21
pubmed: 22213127
Clin Pharmacol Ther. 2012 Jun;91(6):1044-52
pubmed: 22510778
Science. 2012 Jul 6;337(6090):64-9
pubmed: 22604720
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W452-7
pubmed: 22689647
Am J Hum Genet. 2012 Aug 10;91(2):224-37
pubmed: 22863193
Clin Pharmacol Ther. 2012 Oct;92(4):414-7
pubmed: 22992668
PLoS One. 2012;7(10):e46688
pubmed: 23056405
Nature. 2012 Nov 1;491(7422):56-65
pubmed: 23128226
PLoS One. 2012;7(11):e47571
pubmed: 23152756
Front Genet. 2012 Nov 21;3:248
pubmed: 23181071
Curr Protoc Hum Genet. 2013 Jan;Chapter 7:Unit7.20
pubmed: 23315928
Pharmacol Ther. 2013 Apr;138(1):103-41
pubmed: 23333322
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
Clin Pharmacol Ther. 2013 Dec;94(6):640-5
pubmed: 23988873
Pharmacogenomics. 2013 Sep;14(12):1433-48
pubmed: 24024896
Addict Biol. 2015 May;20(3):594-604
pubmed: 24735490
Annu Rev Pharmacol Toxicol. 2015;55:89-106
pubmed: 25292429
Nat Genet. 2015 Jul;47(7):692-5
pubmed: 26111507
Genome Med. 2015 Jul 03;7(1):67
pubmed: 26221186
Pharmacogenet Genomics. 2015 Dec;25(12):584-94
pubmed: 26340336
Clin Pharmacol Ther. 2015 Dec;98(6):611-21
pubmed: 26344676
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Nature. 2015 Oct 15;526(7573):343-50
pubmed: 26469045
Pharmacogenet Genomics. 2016 Jan 5;:
pubmed: 26736087
Clin Pharmacol Ther. 2016 Aug;100(2):160-9
pubmed: 26857349
J Mol Diagn. 2016 May;18(3):438-445
pubmed: 26947514
Genet Med. 2017 Jan;19(1):20-29
pubmed: 27101133
J Transl Med. 2016 Jun 23;14(1):186
pubmed: 27338244
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Clin Pharmacol Ther. 2017 Mar;101(3):396-405
pubmed: 27727443
Trends Pharmacol Sci. 2017 Jan;38(1):100-109
pubmed: 27955861
Pharmacogenet Genomics. 2017 Mar;27(3):89-100
pubmed: 27984508
Curr Pharm Biotechnol. 2017;18(3):204-209
pubmed: 28044932
J Neurochem. 2017 Dec;143(5):507-522
pubmed: 28902413
Genome Med. 2017 Dec 22;9(1):117
pubmed: 29273096
Clin Pharmacol Ther. 2018 May;103(5):795-801
pubmed: 29460273
Hum Genomics. 2018 May 25;12(1):26
pubmed: 29793534
Pharmacogenomics J. 2018 Sep 12;:null
pubmed: 30206299
Front Pharmacol. 2018 Dec 04;9:1437
pubmed: 30564131

Auteurs

Kathrin Klein (K)

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
Medical School, University of Tübingen, Tübingen, Germany.

Roman Tremmel (R)

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
Medical School, University of Tübingen, Tübingen, Germany.

Stefan Winter (S)

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
Medical School, University of Tübingen, Tübingen, Germany.

Sarah Fehr (S)

CeGaT GmbH, Tübingen, Germany.
Praxis für Humangenetik Tübingen, Tübingen, Germany.

Florian Battke (F)

CeGaT GmbH, Tübingen, Germany.
Praxis für Humangenetik Tübingen, Tübingen, Germany.

Tim Scheurenbrand (T)

CeGaT GmbH, Tübingen, Germany.
Praxis für Humangenetik Tübingen, Tübingen, Germany.

Elke Schaeffeler (E)

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
Medical School, University of Tübingen, Tübingen, Germany.

Saskia Biskup (S)

CeGaT GmbH, Tübingen, Germany.
Praxis für Humangenetik Tübingen, Tübingen, Germany.

Matthias Schwab (M)

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
Medical School, University of Tübingen, Tübingen, Germany.
Department of Clinical Pharmacology, University Hospital Tübingen, Tübingen, Germany.
Department of Pharmacy and Biochemistry, University of Tübingen, Tübingen, Germany.

Ulrich M Zanger (UM)

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
Medical School, University of Tübingen, Tübingen, Germany.

Classifications MeSH